Rise Nano Optics Announces Establishment of New SpectraGuard(TM) Nanomaterial Production Facility in Israel

(CSE:EYE) (OTCQB:RNOLF) (FSE:U9Y) Rise Nano Optics Ltd. announced the establishment of a new nanomaterial production facility within Sagam Optical Products Ltd. facilities in Israel, dedicated to manufacturing the Company's proprietary nanomaterial used in its SpectraGuard™ lens technology. The new Rise-operated facility represents a significant expansion and advancement of the Company's existing nanomaterial manufacturing capabilities. The facility will be operational as of November 1, 2026. The new facility is expected to increase Rise's nanomaterial production capacity by approximately 4X compared with its previous manufacturing facility, allowing production of nanomaterial for 80,000 lenses per month. The facility also provides expanded warehousing capabilities and a more streamlined infrastructure for fulfilling nanomaterial orders to Rise's optical laboratory partners globally. SpectraGuard™ technology is a patented nanoparticle optical lens treatment designed to provide eye protection by filtering 100% of ultraviolet (UV) light and up to 90% of wavelengths between 400-600 nm, including blue light, while preserving natural visual clarity and color perception. SpectraGuard nanomaterial is produced by Rise and supplied to authorized optical laboratory partners globally, where it is incorporated into lenses using the Company's proprietary production processes. The new facility is expected to provide approximately 4x the nanomaterial production capacity of the Company's previous manufacturing facility, more advanced production infrastructure, expanded warehousing capabilities, and streamlined global fulfillment capabilities. Rise will operate the new facility and maintain control over the production of its proprietary nanomaterial. Locating the operation within Sagam's facilities allows Rise to expand its manufacturing footprint within an established optical-industry environment while developing dedicated production, inventory, and fulfillment capabilities to support the continued commercialization of SpectraGuard. Sagam is the largest independent lab in Israel, serving optical practices and eye care professionals across Israel and operates its own manufacturing and coating facilities. Erik Ritchie, Chief Commercial Officer of Rise Nano Optics, stated that the commercialization model is designed around enabling established optical laboratories to bring SpectraGuard to their existing customers, and that the new facility is designed to give Rise the capacity and infrastructure to support significantly greater volume and more efficient delivery to lab partners globally. The new facility is part of Rise's broader strategy to establish the manufacturing, laboratory, and distribution infrastructure necessary to support the commercialization of SpectraGuard across multiple geographic markets. By increasing upstream nanomaterial production capacity and expanding its network of authorized optical laboratories, the Company is developing infrastructure intended to support greater commercial scale without requiring Rise to establish finished-lens manufacturing operations in each market it enters.

Customer wins in the US and Central America

(LSE:EYE) Eagle Eye Solutions Group PLC announced two new customer wins in North and Central America, expanding its international footprint. The company has signed multi-year contracts with Stater Bros, a leading Southern California supermarket chain, and Auto Mercado, Costa Rica's premier supermarket chain. Once operational, these two contracts are together expected to generate initial base annual recurring revenue (ARR) of approximately £0.8m, with the potential for further account expansion over time. The agreements add to recent contract renewals with Morrisons in the UK and Musgrave Group in Ireland, as well as recent go-lives with Subway, Kwik Trip, and a major UK health and beauty retailer. Stater Bros will deploy Eagle Eye’s AI-powered personalisation solution, Personalised Challenges, to drive incremental sales and deliver 1:1 personalisation at scale across its hundreds of stores. This agreement further expands Eagle Eye's presence in North America, a key strategic growth market for the Group. Auto Mercado will integrate Eagle Eye’s Personalised Challenges into its existing loyalty programme, with the agreement comprising an initial six-month pilot followed by a three-year contract upon successful pilot completion. Tim Mason, Chief Executive Officer of Eagle Eye, stated that these wins demonstrate the growing demand for the company’s AI-powered loyalty and personalised promotions capabilities and reinforce confidence in Eagle Eye’s global growth opportunity. Each week, more than 1.8 billion personalized offers are executed via Eagle Eye's platform, and over 800 million loyalty member wallets are managed worldwide. Eagle Eye’s technology is API-based, cloud-native, fully certified by the MACH Alliance, and recognized by industry bodies such as Gartner, Forrester, IDC, and QKS.

Rise Nano Optics Joins the Vision Council, a Leading Optical Trade Association, Expanding Access to Key Optical Relationship

(CSE:EYE) (OTCQB:RNOLF) Rise Nano Optics Ltd. announced that it has joined The Vision Council, one of the optical industry's leading trade associations representing hundreds of eyewear manufacturers, lens laboratories, retailers, distributors and technology companies across North America. The membership represents another strategic milestone as Rise continues executing its commercialization strategy for its proprietary SPECTRAGUARD™ lens technology. Members of the Company's management team will be attending the Vision Council 2026 Lab Leadership Forum September 16-18 in Las Vegas, Nevada. SPECTRAGUARD™ is Rise's patented nano-optic lens technology designed to filter up to 90% of high-energy visible light between 400 and 600 nanometers while maintaining natural colour perception and visual clarity. The Company also announces that Nancy Goertzen has resigned from the Company's Board of Directors and from all Board committees on which she served, effective August 19, 2026.

Rise Nano Optics Announces Frankfurt Stock Exchange Listing

(CSE: EYE) (OTCQB: RNOLF) Rise Nano Optics Ltd. announced that its common shares are now listed and trading on the Frankfurt Stock Exchange under the trading symbol "U9Y". The company has engaged Dr. Reuter Investor Relations GmbH, based in Frankfurt, Germany, to provide investor relations and corporate communications services targeting European capital markets, effective August 15, 2026. Dr. Reuter will be paid a cash fee of €6,000 per month for an initial term of six months, ending February 15, 2027, with additional fees possible for investor roadshows and conferences. No stock options or other securities have been granted to Dr. Reuter in connection with the engagement. Rise recently initiated its U.S. commercialization strategy following regulatory progress and continues to execute a multi-channel go-to-market approach targeting optical labs, lens manufacturers, eye care professionals, and eyewear brands. SPECTRAGUARD™ technology is engineered to selectively filter high-energy visible light between 400-600 nm, including blue light, while preserving natural color accuracy and visual clarity. The company projects that expanding access to European investors strengthens its ability to build awareness, drive liquidity, and support long-term growth.

Rise Nano Optics Announces First U.S. Eye Care Professional Partnership with LI Opticians

(CSE:EYE) Rise Nano Optics Ltd. announced its first U.S. eye care professional (ECP) partnership with LI Opticians, an independent optical practice located in Seaford, New York, owned and operated by Barry Santini. The partnership is non-exclusive and evergreen, and will see LI Opticians offer SpectraGuard lenses to its patient base, serving as Rise's first ECP-level commercial partner in the United States. SpectraGuard is a patented nano particle optical lens treatment that filters 100% of ultraviolet (UV) light and up to 90%+ of wavelengths between 400-600 nm, including blue light, while preserving natural visual clarity and color perception. The arrangement provides Rise with access to the clinical channel — opticians and other eye care professionals who interact with patients directly — as part of the Company's strategy to establish ECP relationships ahead of broader distribution. The partnership includes LI Opticians providing clinical feedback to support Rise's ongoing commercialization and product development efforts. Rise's commercialization strategy includes optical lab and clinical channel partnerships, followed by broader consumer and brand integrations. The company states that forward-looking statements in the release involve risks and uncertainties, and actual results may differ materially from those anticipated.

Rise Nano Optics Announces Strategic Partnership with SportifEye Optics to Produce and Commercialize SpectraGuard(TM) Lenses in the United States

(CSE: EYE) Rise Nano Optics Ltd. announced a strategic partnership with SportifEye Optics, a full-service optical laboratory and VSP®-Authorized Lab based in Southern California, to support the production and commercialization of its SpectraGuard lens technology in the United States. The SpectraGuard technology is a patented nano particle optical lens treatment that filters 100% of ultraviolet (UV) light and up to 90% of wavelengths between 400-600 nm, including blue light, while preserving natural visual clarity and color perception. The technology's intended use claim for SPECTRAGUARD™ has been accepted by the FDA in connection with the Company's Class I exempt medical device registration. The partnership is governed by an Authorized Optical Laboratory Agreement between Rise Nano Optics, Inc., the Company's wholly-owned U.S. subsidiary incorporated in Delaware, and SportifEye, Inc., executed and effective as of May 12, 2026. This is the Company's second optical lab partnership in the United States and represents continued execution of its North American commercialization strategy. The Company intends to replicate this model by aligning with additional independent laboratories, creating a distributed manufacturing and fulfillment ecosystem. Rise is positioned to scale efficiently without significant capital investment, while maintaining flexibility across multiple distribution channels.

Notice of Capital Markets Day

Eagle Eye Solutions Group PLC announced it will be hosting a Capital Markets Day for analysts and institutional investors on Thursday 21 May 2026 in London. The event will focus on the Group's positioning within the global personalised marketing revolution, the evolution of its AI-powered products, and its go-to-market strategy. Eagle Eye claims to enable personalised, real-time engagement at scale for retail, travel, and hospitality brands globally, with more than 1 billion personalised offers executed weekly and over 700 million loyalty member wallets managed worldwide. The company's technology is certified by the MACH Alliance and has received recognition from Gartner, Forrester, IDC, and QKS. Existing and prospective retail investors are invited to join via a live webcast.

Market One: Rise Nano Optics Secures First U.S. Lab Partnership as SPECTRAGUARD(TM) Commercialization Advances

(CSE:EYE) Rise Nano Optics Ltd. is commercializing its patented SPECTRAGUARD™ Nanotechnology Lens. Market One, a marketing agency for public companies, shares editorial and video features on emerging growth stories across the resource, energy, and technology sectors.